Cheng-Yi Kuo

Title: Cheng-Yi Kuo: Innovator in Biomedical Applications

Introduction

Cheng-Yi Kuo is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical applications, particularly in the activation of AMP-activated protein kinase (AMPK) and wound healing processes. With a total of 5 patents to his name, Kuo's work has the potential to impact various medical conditions.

Latest Patents

Kuo's latest patents include a method for activating AMPK and the use of adenine. This invention relates to adenine, which is useful for activating AMPK and can be employed in the prevention or treatment of conditions that can be ameliorated by AMPK in mammals. Another notable patent is a method for enhancing wound healing by administering adenine. This patent provides a composition for wound healing that includes adenine and a pharmaceutically acceptable salt thereof, along with a method for enhancing wound healing in subjects in need.

Career Highlights

Cheng-Yi Kuo is associated with Energenesis Biomedical Co., Ltd., where he continues to innovate and develop new biomedical solutions. His work is characterized by a strong focus on practical applications that can lead to improved health outcomes.

Collaborations

Kuo collaborates with notable colleagues such as Han-Min Chen and Chun-Fang Huang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Cheng-Yi Kuo's contributions to biomedical inventions, particularly in the areas of AMPK activation and wound healing, highlight his role as a key innovator in the field. His patents reflect a commitment to advancing medical science and improving patient care.